• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

与非酒精性脂肪性肝炎相关的肝脏基因表达和功能变化。

Hepatic gene expression and functional changes associated with nonalcoholic steatohepatitis.

机构信息

Department of Bioscience and Laboratory Medicine, Graduate School of Health Sciences, Japan.

Department of Medical Technology, School of Health Sciences, Hirosaki University, Hirosaki, Aomori 036‑8564, Japan.

出版信息

Mol Med Rep. 2022 Nov;26(5). doi: 10.3892/mmr.2022.12841. Epub 2022 Sep 2.

DOI:10.3892/mmr.2022.12841
PMID:36052866
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9727582/
Abstract

Non‑alcoholic steatohepatitis (NASH) is a pathological condition of the liver in which hepatocyte steatosis, invasion of inflammatory cells and hepatic injury occur without alcohol abuse. Despite the known risk of liver cancer and liver fibrosis that may progress to liver cirrhosis that exists with NASH, an understanding of related gene expression and associated functional changes remains insufficient. The present study used a mouse model of NASH induced by a high‑fat diet to examine gene expression in the liver and to search for transcripts that could predict early liver fibrosis in the future. Mice fed a high‑fat diet for 2 weeks showed typical NASH liver histology by hematoxylin and eosin staining, and increased fibrosis was confirmed by Sirius red staining after 6 weeks. Functional changes associated with liver damage, liver inflammation, liver steatosis and liver fibrosis were predicted by toxicological ontology analysis using Ingenuity Pathways Analysis. Downregulated microRNA (miR)‑21 and upregulated mRNA in the liver and upregulated exosomal miR‑21 in serum of mice fed a high‑fat diet for 1 and/or 2 weeks were confirmed by reverse transcription‑quantitative PCR, suggesting that these changes occur prior to histological confirmation of fibrosis. Therefore, it may be possible to predict future liver fibrosis by analyzing fibrosis‑related genes that shift prior to pathological findings.

摘要

非酒精性脂肪性肝炎(NASH)是一种肝脏的病理状态,其特征为肝细胞脂肪变性、炎症细胞浸润和肝损伤,而无酒精滥用。尽管已知 NASH 存在肝癌和肝纤维化的风险,后者可能进展为肝硬化,但对相关基因表达和相关功能变化的了解仍不充分。本研究采用高脂肪饮食诱导的 NASH 小鼠模型,研究肝脏中的基因表达,并寻找可能预测未来肝纤维化的转录本。用高脂肪饮食喂养 2 周的小鼠通过苏木精和伊红染色显示出典型的 NASH 肝组织学,6 周后通过天狼星红染色证实纤维化增加。用 IPA 进行毒理学本体分析预测与肝损伤、肝炎症、肝脂肪变性和肝纤维化相关的功能变化。通过逆转录定量 PCR 证实了用高脂肪饮食喂养 1 周和/或 2 周的小鼠肝脏中 miR-21 下调和 mRNA 上调,以及血清外泌体 miR-21 上调,表明这些变化发生在纤维化的组织学确认之前。因此,通过分析纤维化相关基因在出现病理发现之前的变化,可能可以预测未来的肝纤维化。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7beb/9727582/fed96291f30c/mmr-26-05-12841-g03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7beb/9727582/96d89b3c6fc6/mmr-26-05-12841-g00.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7beb/9727582/79b08ca7df9e/mmr-26-05-12841-g01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7beb/9727582/091beff7e627/mmr-26-05-12841-g02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7beb/9727582/fed96291f30c/mmr-26-05-12841-g03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7beb/9727582/96d89b3c6fc6/mmr-26-05-12841-g00.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7beb/9727582/79b08ca7df9e/mmr-26-05-12841-g01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7beb/9727582/091beff7e627/mmr-26-05-12841-g02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7beb/9727582/fed96291f30c/mmr-26-05-12841-g03.jpg

相似文献

1
Hepatic gene expression and functional changes associated with nonalcoholic steatohepatitis.与非酒精性脂肪性肝炎相关的肝脏基因表达和功能变化。
Mol Med Rep. 2022 Nov;26(5). doi: 10.3892/mmr.2022.12841. Epub 2022 Sep 2.
2
Metabolic and hepatic effects of liraglutide, obeticholic acid and elafibranor in diet-induced obese mouse models of biopsy-confirmed nonalcoholic steatohepatitis.利拉鲁肽、奥贝胆酸和 Elafibranor 在经活检证实的非酒精性脂肪性肝炎肥胖小鼠模型中的代谢和肝脏作用。
World J Gastroenterol. 2018 Jan 14;24(2):179-194. doi: 10.3748/wjg.v24.i2.179.
3
The American lifestyle-induced obesity syndrome diet in male and female rodents recapitulates the clinical and transcriptomic features of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis.美国生活方式引起的肥胖综合征饮食在雄性和雌性啮齿动物中再现了非酒精性脂肪性肝病和非酒精性脂肪性肝炎的临床和转录组特征。
Am J Physiol Gastrointest Liver Physiol. 2020 Sep 1;319(3):G345-G360. doi: 10.1152/ajpgi.00055.2020. Epub 2020 Aug 5.
4
Pan-caspase inhibitor VX-166 reduces fibrosis in an animal model of nonalcoholic steatohepatitis.泛半胱天冬酶抑制剂VX-166可减轻非酒精性脂肪性肝炎动物模型中的纤维化。
Hepatology. 2009 Nov;50(5):1421-30. doi: 10.1002/hep.23167.
5
Inhibiting Interleukin 11 Signaling Reduces Hepatocyte Death and Liver Fibrosis, Inflammation, and Steatosis in Mouse Models of Nonalcoholic Steatohepatitis.抑制白细胞介素 11 信号通路可减少非酒精性脂肪性肝炎小鼠模型中的肝细胞死亡及肝纤维化、炎症和脂肪变性。
Gastroenterology. 2019 Sep;157(3):777-792.e14. doi: 10.1053/j.gastro.2019.05.002. Epub 2019 May 9.
6
Disruption of hepatic small heterodimer partner induces dissociation of steatosis and inflammation in experimental nonalcoholic steatohepatitis.肝小异二聚体伴侣的破坏可诱导实验性非酒精性脂肪性肝炎中脂肪变性和炎症的分离。
J Biol Chem. 2020 Jan 24;295(4):994-1008. doi: 10.1074/jbc.RA119.010233. Epub 2019 Dec 12.
7
Diallyl disulfide attenuates non‑alcoholic steatohepatitis by suppressing key regulators of lipid metabolism, lipid peroxidation and inflammation in mice.二烯丙基二硫醚通过抑制小鼠脂质代谢、脂质过氧化和炎症的关键调节因子来减轻非酒精性脂肪性肝炎。
Mol Med Rep. 2019 Aug;20(2):1363-1372. doi: 10.3892/mmr.2019.10316. Epub 2019 May 31.
8
microRNA-122 regulates hypoxia-inducible factor-1 and vimentin in hepatocytes and correlates with fibrosis in diet-induced steatohepatitis.微小RNA-122调节肝细胞中的缺氧诱导因子-1和波形蛋白,并与饮食诱导的脂肪性肝炎中的纤维化相关。
Liver Int. 2015 Feb;35(2):532-41. doi: 10.1111/liv.12633. Epub 2014 Jul 28.
9
A Cholecystokinin Receptor Antagonist Halts Nonalcoholic Steatohepatitis and Prevents Hepatocellular Carcinoma.一种胆囊收缩素受体拮抗剂可阻止非酒精性脂肪性肝炎并预防肝细胞癌。
Dig Dis Sci. 2020 Jan;65(1):189-203. doi: 10.1007/s10620-019-05722-3. Epub 2019 Jul 11.
10
Targeting hepatic miR-221/222 for therapeutic intervention of nonalcoholic steatohepatitis in mice.靶向小鼠肝 miR-221/222 治疗非酒精性脂肪性肝炎。
EBioMedicine. 2018 Nov;37:307-321. doi: 10.1016/j.ebiom.2018.09.051. Epub 2018 Oct 10.

引用本文的文献

1
Fluorofenidone attenuates choline-deficient, l-amino acid-defined, high-fat diet-induced metabolic dysfunction-associated steatohepatitis in mice.氟非尼酮减轻胆碱缺乏、L-氨基酸限定、高脂饮食诱导的小鼠代谢功能障碍相关脂肪性肝炎。
Sci Rep. 2025 Mar 21;15(1):9863. doi: 10.1038/s41598-025-94401-7.
2
Changes in Macronutrients during Dieting Lead to Weight Cycling and Metabolic Complications in Mouse Model.节食期间常量营养素的变化导致小鼠模型出现体重循环和代谢并发症。
Nutrients. 2024 Feb 25;16(5):646. doi: 10.3390/nu16050646.

本文引用的文献

1
Global epidemiology of NAFLD-related HCC: trends, predictions, risk factors and prevention.非酒精性脂肪性肝病相关肝细胞癌的全球流行病学:趋势、预测、危险因素和预防。
Nat Rev Gastroenterol Hepatol. 2021 Apr;18(4):223-238. doi: 10.1038/s41575-020-00381-6. Epub 2020 Dec 21.
2
Long-term profile of serological biomarkers, hepatic inflammation, and fibrosis in a mouse model of non-alcoholic fatty liver disease.非酒精性脂肪性肝病小鼠模型中血清生物标志物、肝脏炎症和纤维化的长期概况
Toxicol Lett. 2020 Oct 10;332:1-6. doi: 10.1016/j.toxlet.2020.06.020. Epub 2020 Jun 21.
3
Nonalcoholic Fatty Liver Disease 2020: The State of the Disease.
2020年非酒精性脂肪性肝病:疾病现状
Gastroenterology. 2020 May;158(7):1851-1864. doi: 10.1053/j.gastro.2020.01.052. Epub 2020 Feb 13.
4
The Role of Noninvasive Tests for Differentiating NASH From NAFL and Diagnosing Advanced Fibrosis Among Patients With NAFLD.非侵入性检查在区分非酒精性脂肪性肝炎与非酒精性脂肪肝以及诊断非酒精性脂肪性肝病患者的晚期纤维化中的作用。
J Clin Gastroenterol. 2020 Feb;54(2):107-113. doi: 10.1097/MCG.0000000000001284.
5
Type III collagen (COL3A1): Gene and protein structure, tissue distribution, and associated diseases.III 型胶原(COL3A1):基因和蛋白质结构、组织分布及相关疾病。
Gene. 2019 Jul 30;707:151-171. doi: 10.1016/j.gene.2019.05.003. Epub 2019 May 7.
6
Global Perspectives on Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis.全球视角下的非酒精性脂肪性肝病和非酒精性脂肪性肝炎。
Hepatology. 2019 Jun;69(6):2672-2682. doi: 10.1002/hep.30251.
7
miR-223 Deficiency Protects against Fas-Induced Hepatocyte Apoptosis and Liver Injury through Targeting Insulin-Like Growth Factor 1 Receptor.微小RNA-223缺陷通过靶向胰岛素样生长因子1受体来预防Fas诱导的肝细胞凋亡和肝损伤。
Am J Pathol. 2015 Dec;185(12):3141-51. doi: 10.1016/j.ajpath.2015.08.020.
8
Performance of Serum microRNAs -122, -192 and -21 as Biomarkers in Patients with Non-Alcoholic Steatohepatitis.血清微小RNA-122、-192和-21作为非酒精性脂肪性肝炎患者生物标志物的性能
PLoS One. 2015 Nov 13;10(11):e0142661. doi: 10.1371/journal.pone.0142661. eCollection 2015.
9
Liver microRNA-21 is overexpressed in non-alcoholic steatohepatitis and contributes to the disease in experimental models by inhibiting PPARα expression.肝脏微小RNA-21在非酒精性脂肪性肝炎中过度表达,并通过抑制过氧化物酶体增殖物激活受体α(PPARα)的表达在实验模型中导致该疾病。
Gut. 2016 Nov;65(11):1882-1894. doi: 10.1136/gutjnl-2014-308883. Epub 2015 Sep 3.
10
MicroRNA profiles following metformin treatment in a mouse model of non-alcoholic steatohepatitis.非酒精性脂肪性肝炎小鼠模型中二甲双胍治疗后的微小RNA谱
Int J Mol Med. 2015 Apr;35(4):877-84. doi: 10.3892/ijmm.2015.2092. Epub 2015 Feb 6.